Marinus Pharmaceuticals reported $69.93M in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Acadia Pharmaceuticals ACAD:US $ 0M 0M
ALKERMES ALKS:US $ 295.17M 0.63M
Amgen AMGN:US $ 36854M 3545M
Aptinyx Inc APTX:US $ 24.29M 10.14M
Biogen BIIB:US $ 7275.2M 2.1M
Eisai 4523:JP Y 135758M 45837M
Enanta Pharmaceuticals ENTA:US $ 1.51M 0M
Esperion Therapeutics ESPR:US $ 258.68M 398K
Gilead Sciences GILD:US $ 26208M 487M
Intercept Pharmaceuticals ICPT:US $ 716.88M 177.1M
Intra Cellular Therapies ITCI:US $ 0M 0M
Marinus Pharmaceuticals MRNS:US $ 69.93M 29.12M
Minerva Neurosciences NERV:US $ 0M 0M
Neurocrine Biosciences NBIX:US $ 377.7M 42.6M
Ptc Therapeutics PTCT:US $ 1197.09M 8.62M
Regeneron Pharmaceuticals REGN:US $ 2700.4M 0.7M
Sarepta Therapeutics SRPT:US $ 1098.85M 1.97M
Supernus Pharmaceuticals SUPN:US $ 400.38M 21.13M
Vertex Pharmaceuticals VRTX:US $ 495.5M 14.3M
YTE INCY:US $ 34.18M 0.09M